medigraphic.com
SPANISH

Revista Cubana de Farmacia

ISSN 1561-2988 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 3

<< Back Next >>

Rev Cubana Farm 2014; 48 (3)

Development of a stable formulation of liquid urease for determination of serum urea

García BL, Rodríguez FB, Aja MG, Pérez CJA, Russeaux GN, Valdés DL, Licea TMV
Full text How to cite this article

Language: Spanish
References: 6
Page: 396-404
PDF size: 156.48 Kb.


Key words:

urease, urea, clinical diagnosis, clinical laboratory.

ABSTRACT

Introduction: determination of serum urea has great importance for the clinical diagnosis of several renal illnesses. The most implemented methods involve the use of the urease enzyme because of its high specificity for this analyte hydrolysis; the Berthelot method uses urease in the first reaction step followed by colorimetric reaction of the released ammonium. The presentation of urease in liquid form is one of the elements that make this process simpler, of easy and fast application with reliable results.
Objective: to develop a stable urease solution as part of the diagnostic set for serum urea.
Methods: the adequate formulation was designed and optimized by taking into account the enzyme concentration, the buffer solutions, the preserves and the polyhydroxyled organic compounds to attain a final stable liquid product. The parameters called specificity, precision, linearity, accuracy (comparison of methods) and sensitivity of the method were all evaluated in addition to the shelf life at 2 a 8 °C for 18 months.
Results: astable liquid reagent (over 12 months at 2 a 8 °C ) was reached; the analytical method proved to be specific and linear up to 30 mmol/L of urea (r2= 0,999), sensitive, precise, with variation coefficient lower than 3 % and accurate ((r ≥ 0,999), satisfactory for the intended use of the product and the analytical quality comparable to that of the already existing products.
Conclusions: the development of the stable liquid urease formulation will allow introducing this essential component in the reagent set for urea offered by the national industry to the healthcare system according to the requirements for commercialization (Reg 8-2001).


REFERENCES

  1. Berg Jeremy M, Tymoczko John L, Stryer L. Biochemistry. 6th ed. London: W.H. Freeman and Company; 2011. p. 205-38.

  2. Copeland A, Allen R. Evaluation of enzyme inhibitors in drug discovery a guide for medicinal chemists and pharmacologists. Vol 46. Hoboken, New Jersey: John Wiley & Sons; 2007.

  3. Pazhang MKK, Ranjbar B, Hosseinkhani S. Effects of water-miscible solvents and polyhydroxy compounds on the structure and enzymatic activity of thermolysin. Rev J Biotechnol. 2006;127(1):45-53.

  4. Catálogo de Productos de Sistemas Diagnósticos Diasys 2012. Holzheim, Alemania: Grafikdesign; 2012.

  5. Regulación D 08-13. Reglamento para la autorización de comercialización de los diagnosticadores. La Habana: CECMED; 2013.

  6. Panteghini MBR, Van Solinge WW. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. Philadelphia: Elsevier Saunders; 2006.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Farm. 2014;48